Results 121 to 130 of about 1,399 (226)

The association between levonorgestrel intrauterine devices and female fertility compared to other contraceptive methods: A historical cohort study. [PDF]

Int J Gynaecol Obstet
Michaelsen MP, Nielsen LC, Poulsen M, Skals RG, Lundbye-Christensen S, Kesmodel US.   +5 more
europepmc   +1 more source

Hormonal profiles of eumenorrheic women compared to hormonal intrauterine device users

Physiological Reports, Volume 14, Issue 7, April 2026.
Abstract The hormonal intrauterine device (hIUD) induces local changes to reproductive biology (e.g., uterus, endometrium) and has some systemic physiological effects (e.g., hormones, mood, etc.). However, the systemic hormonal changes observed in women with eumenorrheic (EUM) cycles have not been thoroughly investigated in hIUD users.
Brooklyn M. Wiggins, Aarzo Karimi, Patricia K. Doyle‐Baker, Saied Jalal Aboodarda   +3 more
wiley   +1 more source

Subdermal implants vs. levonorgestrel intrauterine devices outcomes in reproductive-aged women: a systematic review and meta-analysis. [PDF]

Arch Gynecol Obstet
Oliveira JA, Neves GL, Pinhati MES, de Oliveira FR, Filho ALDS.   +4 more
europepmc   +1 more source

Why Pakistani Women Do Not Use Intrauterine Contraceptive Devices: A Systematic Review of Barriers and Misconceptions. [PDF]

Cureus, 2023
Sajjad W, Ishaq K, Asghar S.
europepmc   +1 more source

Levonorgestrel-releasing intrauterine device treatment in heavy menstrual bleeding: Correlation with endometrial pathology and quality of life. [PDF]

PLoS One
Kolcu SA, Kara E, Yıldız E, Çetin A.
europepmc   +1 more source

POLE-mutated atypical endometrial hyperplasia in an adolescent: a 5-year follow-up with LNG-IUS-a case report and literature review. [PDF]

BMC Womens Health
Liu J, Han Y, Wu S.
europepmc   +1 more source

Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice. [PDF]

Rev Bras Ginecol Obstet, 2023
de Oliveira ECF, Rocha ALL.
europepmc   +1 more source

Risks of pelvic inflammatory disease and bacterial vaginosis in adenomyosis patients using levonorgestrel intrauterine device or oral norethindrone. [PDF]

Front Endocrinol (Lausanne)
Niu SY, Yi YC, Shih YH, Tseng JJ.
europepmc   +1 more source

Intrauterine devices for menorrhagia. [PDF]

Can Fam Physician, 2023
Potter J, Lindblad AJ.
europepmc   +1 more source

Conservative hysteroscopic treatment of endometrial intraepithelial neoplasia and endometrial cancer in patients with high surgical risk with mechanical hysteroscopic tissue removal systems: A retrospective cohort study. [PDF]

Int J Gynaecol Obstet
Arena A, Franceschini C, Mantovani E, Virgilio A, Bettiol E, Guerrini M, di Spiezio Sardo A, De Angelis MC, Seracchioli R, Casadio P.   +9 more
europepmc   +1 more source